DZ2563A1 - Composition contenant un sensibilisant à l'insuline un secrétagogue d'insuline et un biguanide anti-hyperglycérnique inhibiteur d'alpha-glucosidase. - Google Patents

Composition contenant un sensibilisant à l'insuline un secrétagogue d'insuline et un biguanide anti-hyperglycérnique inhibiteur d'alpha-glucosidase.

Info

Publication number
DZ2563A1
DZ2563A1 DZ980173A DZ980173A DZ2563A1 DZ 2563 A1 DZ2563 A1 DZ 2563A1 DZ 980173 A DZ980173 A DZ 980173A DZ 980173 A DZ980173 A DZ 980173A DZ 2563 A1 DZ2563 A1 DZ 2563A1
Authority
DZ
Algeria
Prior art keywords
insulin
hyperglycerinic
biguanide
alpha
composition containing
Prior art date
Application number
DZ980173A
Other languages
English (en)
Inventor
Stephen Alistair Smith
Robin Edwin Buckingham
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DZ2563A1 publication Critical patent/DZ2563A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
DZ980173A 1997-07-18 1998-07-15 Composition contenant un sensibilisant à l'insuline un secrétagogue d'insuline et un biguanide anti-hyperglycérnique inhibiteur d'alpha-glucosidase. DZ2563A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715298A GB9715298D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
DZ2563A1 true DZ2563A1 (fr) 2003-02-15

Family

ID=10816170

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980173A DZ2563A1 (fr) 1997-07-18 1998-07-15 Composition contenant un sensibilisant à l'insuline un secrétagogue d'insuline et un biguanide anti-hyperglycérnique inhibiteur d'alpha-glucosidase.

Country Status (27)

Country Link
EP (1) EP1001784A1 (fr)
JP (1) JP2001510160A (fr)
KR (1) KR20010021952A (fr)
CN (1) CN1263467A (fr)
AP (1) AP2000001735A0 (fr)
AR (2) AR016350A1 (fr)
AU (1) AU8449098A (fr)
BG (1) BG104062A (fr)
BR (1) BR9810292A (fr)
CA (1) CA2297133A1 (fr)
CO (1) CO4940489A1 (fr)
DZ (1) DZ2563A1 (fr)
EA (1) EA200000140A1 (fr)
GB (1) GB9715298D0 (fr)
HU (1) HUP0003626A3 (fr)
ID (1) ID23804A (fr)
IL (1) IL133907A0 (fr)
MA (1) MA24608A1 (fr)
NO (1) NO20000230L (fr)
OA (1) OA11312A (fr)
PE (1) PE99499A1 (fr)
PL (1) PL338140A1 (fr)
SK (1) SK612000A3 (fr)
TR (1) TR200000133T2 (fr)
UY (1) UY25101A1 (fr)
WO (1) WO1999003478A1 (fr)
ZA (1) ZA986364B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
SI1133312T1 (sl) * 1999-06-21 2008-02-29 Lilly Co Eli Uporaba tiazolidindionov v kombinaciji z glukagonu podobnim peptidom-1 in njegovimi agonisti za zdravljenje sladkorne bolezni, neodvisne od inzulina
ATE385421T1 (de) * 2000-01-21 2008-02-15 Novartis Pharma Gmbh Zusammensetzungen bestehend aus dipeptidylpeptidase-iv inhibitoren und antidiabetica
WO2001062295A1 (fr) * 2000-02-24 2001-08-30 Takeda Chemical Industries, Ltd. Medicaments contenant des ingredients actifs combines
JP4917712B2 (ja) * 2000-02-24 2012-04-18 武田薬品工業株式会社 併用医薬
US7964216B2 (en) 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
FR2832930A1 (fr) * 2001-12-03 2003-06-06 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
TWI339586B (en) 2003-10-31 2011-04-01 Takeda Chemical Industries Ltd Solid preparation comprising pioglitazone or salt thereof,glimpiride and polyoxyethylene sorbitan fatty acid ester
CN101103993B (zh) * 2006-07-14 2011-03-30 北京华安佛医药研究中心有限公司 降糖药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06510286A (ja) * 1991-08-26 1994-11-17 ファルマシア・アンド・アップジョン・カンパニー ３−グアニジノプロピオン酸およびピオグリタゾン、グリベンクラミドまたはグリメピリドを含有する医薬組成物
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes

Also Published As

Publication number Publication date
BG104062A (en) 2000-11-30
TR200000133T2 (tr) 2000-09-21
GB9715298D0 (en) 1997-09-24
IL133907A0 (en) 2001-04-30
AR019724A2 (es) 2002-03-13
WO1999003478A1 (fr) 1999-01-28
KR20010021952A (ko) 2001-03-15
NO20000230D0 (no) 2000-01-17
EP1001784A1 (fr) 2000-05-24
NO20000230L (no) 2000-01-17
CN1263467A (zh) 2000-08-16
ID23804A (id) 2000-05-11
AP2000001735A0 (en) 2000-01-16
BR9810292A (pt) 2000-09-19
PE99499A1 (es) 1999-12-18
ZA986364B (en) 2000-01-17
HUP0003626A2 (hu) 2001-05-28
AU8449098A (en) 1999-02-10
SK612000A3 (en) 2000-07-11
OA11312A (en) 2003-10-24
CA2297133A1 (fr) 1999-01-28
PL338140A1 (en) 2000-09-25
UY25101A1 (es) 2000-12-29
MA24608A1 (fr) 1999-04-01
HUP0003626A3 (en) 2001-12-28
AR016350A1 (es) 2001-07-04
EA200000140A1 (ru) 2000-06-26
JP2001510160A (ja) 2001-07-31
CO4940489A1 (es) 2000-07-24

Similar Documents

Publication Publication Date Title
EP0684044A3 (fr) Composition contenant un dendrimer et une substance active.
EP0578507A3 (fr) Composition de nettoyage à base d'un composé aminé redox.
DZ2562A1 (fr) Composition contenant un sensibilisant à l'insuline un secrétagogue d'insuline et un biguanide anti-hyperglycémique.
NO20001602L (no) Visittkortagent
NO990854L (no) Substituerte N-[(aminiminmetyl- eller aminmetyl)fenyl]-propylamider
BR9504791B1 (pt) composto de polipeptìdeo e composição farmacêutica.
FR2719242B1 (fr) Pompe à précompression perfectionnée.
DZ2086A1 (fr) Benzylaminopipéridines substituées et compositionspharmaceutiques les contenant.
ITFI930083A1 (it) Composti pirrol-amidinici, processi di preparazione e composizioni farmaceutiche che li contengono.
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
EP0628925A3 (fr) Imprimante d'étiquettes.
DZ2937A1 (fr) Compositions nouvelles de sensibilidants à l'insuline.
ITTO930610A1 (it) Composizione a base di 1, 1, 1, 3, 3, -pentafluorobutano e di cloruro di metilene per la pulitura e/o essicazione di superfici solide.
MA24608A1 (fr) Compositions contenant un sensibilisant a l'insuline, un secretagogue d'insuline et un agent anti-heperglycemique inhibiteur d'alphat-glugosidase.
DE69418763D1 (de) Statischer Gewinn durch ATM-Signalisierung
CH684920GA3 (fr) Pièce d'horlogerie.
MA23426A1 (fr) Composition fongicide a base d'iprodione et d'un compose triazole.
FR2705815B1 (fr) Borne d'informations sensitive.
NO985261D0 (no) 1,4-Diaryl-2,3-difluor-2-buten insekticide og akaricide midler
IT232233Y1 (it) Macchina per la gestione di servizi, in particolare giochi e relative informazioni.
IT1274915B (it) Unita' modulare per il contenimento di fiale, fialoidi e similari.
KR940026478U (ko) 명함지
KR960004331U (ko) 명함 케이스
KR950022994U (ko) 명함케이스
KR950017361U (ko) 개량 명함갑